AUTHOR
Interactive Brokers Traders Insight
Interactive Brokers Traders’ Insight (IBTI) is a venue for market-related articles and commentary covering an array of asset classes and topics. All articles published on Traders’ Insight are simultaneously published directly to our trading platform (TWS).
286 posts You may also like
Tesco has a robust future despite recent setbacks.
Update from Opportunistic and Adventurous portfolio manager John Linnemeier.
The absolute price momentum of equity funds is declining.
Limiting portfolio sizes to 20-30 stocks allows for diversification without getting to levels of diworstification. Hence, I have always had a few ‘risky’ biotech stocks. Based on the results of Savient Pharma (SVNT) the rewards have clearly outweighed the risks. Additionally, Rigel Pharma (RIGL) and Cephalon (CEPH) have seen bullish trading of late. Not being predisposed to investing in this sector, I just found the valuations too compelling.